bristol-myers glp-1 receptor agonist products Frontiers GLP-1 Receptor Agonists Reduce Adverse
Description
Can they cause dehydration
For pancreatitis, there was a 0.5% incidence of pancreatitis in people taking Ozempic, a 0.8% risk in people taking Saxenda, and a 0.01% incidence in people taking Contrave, representing a more than ninefold increase
What happens if I stop taking a GLP-1
doi: 10.1210/en.2009-0915
3 The potential CV and renal effects of linagliptin have been investigated in the CAROLINA and CARMELINA trials
